Royalty Pharma Plc (RPRX)
45.40
-0.06
(-0.14%)
USD |
NASDAQ |
Feb 24, 16:00
45.40
0.00 (0.00%)
After-Hours: 18:53
Royalty Pharma Profit Margin (Quarterly) : 57.23% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Denali Therapeutics, Inc. | -- |
| PTC Therapeutics, Inc. | -81.96% |
| Veru, Inc. | -- |
| Incyte Corp. | 19.86% |
| Vertex Pharmaceuticals, Inc. | 36.91% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.52% |
| Return on Assets | 7.11% |
| Return on Invested Capital | 7.34% |
| Gross Profit Margin (Quarterly) | 99.81% |
| Operating Margin (Quarterly) | 62.38% |
| Return on Net Operating Assets | 7.86% |